Pain management in children with erythromelalgia: case report
Tratamento da dor em criança com eritromelalgia: relato de caso
Estela Irene Bortoli; Rioko Kimiko Sakata
Abstract
Keywords
Resumo
Palavras-chave
References
Layzer RB. Hot feet: erythromelalgia and related disorders. J Child Neurol. 2001;16:199-202.
Kalgaard OM, Seem E, Kvernebo K. Erythromelalgia: a clinical study of 87 cases. J Intern Med. 1997;242:191-7.
Yang Y, Wang Y, Li S. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet. 2004;41:171-4.
Dib-Hajj SD, Rush AM, Cummins TR. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain. 2005;128:1847-54.
Uno H, Parker F. Autonomic innervation of the skin in primary erythermalgia. Arch Dermatol. 1983;119:65-71.
Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol. 2000;43:841-7.
Drenth JP, Finley WH, Breedveld GJ. The primary erythermalgia-susceptibility gene is located on chromosome 2q31–. Am J Hum Gen. 2001;68:1277-82.
Davis MD, O’Fallon WM, Rogers 3rd RS. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136:330.
Zhaoli T, Zhao C, Beisha T. Primary erythromelalgia: a review. Orphanet J Rare Dis. 2015;10:127.
Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J. Neurosci. 2004;24:8232.
Norton JV, Zager E, Grady JF. Erythromelalgia: diagnosis and classification. Foot Ankle Surg. 1999;38:238-41.
Alhadad A, Wollmer P, Svensson A. Erythromelalgia: incidence and clinical experience in a single centre in Sweden. Vasa. 2012;41:43.
Reed KB, Davis MD. Incidence of erythromelalgia: a population-based study in Olmsted County Minnesota. J Eur Acad Dermatol Venereol. 2009;23:13-5.
Cook-Norris RH, Tollefson MM, Cruz-Inigo AE. Pediatric erythromelalgia: a retrospective review of 32 cases evaluated at Mayo Clinic over a 37-year period. J Am Acad Dermatol. 2012;66:416.
Mork C, Asker CL, Salerud EG. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000;114:643.
Sandroni P, Davis MD, Harper CM. Neurophysiologic and vascular studies in erythromelalgia: a retrospective analysis. J Clin Neuromuscul Dis. 1999;1:57.
Davis MD, Sandroni P, Rooke TW. Erythromelalgia: vasculopathy, neuropathy, or both? A prospective study of vascular and neurophysiologic studies in erythromelalgia. Arch Dermatol. 2003;139:1337.
William GM, James BD, Peter JD. Epidermal nerve fiber quantification in patients with erythromelalgia. JAMA Dermatol. 2017;153:162-7.
Davis MD, Weenig RH, Genebriera J. Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density. J Am Acad Dermatol. 2006;55:519.
McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology. 1997;86:988.
Kakizaki A, Fujimura T, Kambayashi Y. Successful treatment of adult-onset erythromelalgia with steroid pulse and pregabalin. Case Rep Dermatol. 2012;4:242.
DiCaudo DJ, Kelley LA. Arch alleviation of erythromelalgia with venlafaxine. Dermatology. 2004;140:621-3.
Kuhnert SM, Phillips WJ, Davis MD. Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol. 1999;135:1447.
Fischer TZ, Gilmore ES, Estacion M. A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia. Ann Neurol. 2009;65:733.